INCYTE ANNOUNCES FUNDING OF MINJUVI® (TAFASITAMAB) FOR PATIENTS WITH RELAPSED OR REFRACTORY FOLLICULAR LYMPHOMA THROUGH ONTARIO'S FAST PROGRAM

Reuters · 2d ago

Please log in to view news